Experienced in Hypothalamic Hamartomas

Nicolas Andre

Ap Hm
Marseille, FR 
Experienced in Hypothalamic Hamartomas
Ap Hm
Marseille, FR 
OverviewLocationsClinical Research

Overview

Nicolas Andre practices in Marseille, France. Mr. Andre is rated as an Experienced expert by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Medulloblastoma, Gliomatosis Cerebri, and Posterior Fossa Tumor.

His clinical research consists of co-authoring 204 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hypothalamic Hamartomas.

Gender
Male

Locations

AP HM
Marseille, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Single-arm, Multicenter Phase I/Ib Study of Avelumab + Lenvatinib in Children With Primary CNS Tumors
Single-arm, Multicenter Phase I/Ib Study of Avelumab + Lenvatinib in Children With Primary CNS Tumors
Enrollment Status: Active_not_recruiting
Publish Date: October 17, 2025
Intervention Type: Drug
Study Phase: Phase 1
Phase I Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors
Phase I Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors
Enrollment Status: Completed
Publish Date: September 22, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Multicentre, Open-Label, Dose-Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Patients With Recurrent or Refractory Solid Tumours
A Phase 1, Multicentre, Open-Label, Dose-Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Patients With Recurrent or Refractory Solid Tumours
Enrollment Status: Terminated
Publish Date: July 16, 2025
Intervention Type: Drug
Study Phase: Phase 1
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Enrollment Status: Completed
Publish Date: November 18, 2020
Intervention Type: Drug
Study Phase: Phase 2
Review of the Paediatric Pleuropulmonary Blastoma French Series
Review of the Paediatric Pleuropulmonary Blastoma French Series
Enrollment Status: Completed
Publish Date: August 12, 2020
Intervention Type: Other
Motivations and Psychological Aspects of the Gametes' Donation
Motivations and Psychological Aspects of the Gametes' Donation
Enrollment Status: Completed
Publish Date: July 16, 2019
Intervention Type: Other
View 5 Less Clinical Trials

204 Total Publications

Near Complete Response With Trastuzumab Deruxtecan in a Teenager With Relapsing Metastatic Desmoplastic Small Round Cell Tumor.
Near Complete Response With Trastuzumab Deruxtecan in a Teenager With Relapsing Metastatic Desmoplastic Small Round Cell Tumor.
Journal: Pediatric blood & cancer
Published: August 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Andre's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 37 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile